This report shares highlights of PATH's use of flexible funding in 2009, featuring our work to improve nutrition using sweet potatoes in rural Africa, to encourage gender equality and healthy behavior among children in Nicaragua, and to save women’s lives by using oxytocin in the BD Uniject® device in Argentina.

Publication date: September 2010

Region: Global

Part of series: Reports to contributors

Through PROMDAN, agencies in Thailand and Cambodia responded to the issue of uninformed labor migration. The project aimed to increase access to health services and make labor migration beneficial for migrants and their families. This report documents the development, implementation, and impact of the project.

Publication date: March 2010

Region: Asia

Cervical Cancer Action is a global partnership chaired by PATH and aimed at reducing cervical cancer in high-burden, low-income countries. Seven years after its founding and eight years after human papillomavirus vaccines first became available, Cervical Cancer Action offers this snapshot of its accomplishments to date and its vision of the work ahead.

Publication date: April 2014

Region: Global

Supported by a seed grant from the World Bank, PATH began to focus on cervical cancer in 1991. Since then, our portfolio has expanded tremendously, thanks in large part to grants from the Bill & Melinda Gates Foundation. In this report, we describe our key cervical cancer prevention initiatives.

Publication date: April 2013

Region: Global

This is one of a series of fact sheets that describe PATH's current and past work in Kenya. The fact sheets focus on specific projects as well as unique approaches that cut across projects. This fact sheet describes the work of the Western Kenya Cervical Cancer Prevention Project.

Publication date: June 2006

Region: Africa

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It examines the second component of a successful cervical cancer prevention program—screening and treatment of adult women for precancerous lesions—based on human papillomavirus (HPV) vaccination demonstration projects that PATH conducted from 2006 to 2011 in India, Peru, Uganda, and Vietnam.

Publication date: 2013

Region: Global

This booklet summarizes and updates the World Health Organization (WHO) document Human Papillomavirus and HPV Vaccine: Technical Information for Policy-Makers and Health Professionals and the WHO/UNFPA guidance note Preparing for the Introduction of HPV Vaccines—Policy and Programme Guidance for Countries. They are available in the STIs/RTIs section of the WHO website.

Publication date: 2007

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, easy-to-read, low-cost test for Chagas disease.

Publication date: July 2013

Region: Global

Part of series: Technology Updates

This two-page policy brief discusses the benefits of breastfeeding in light of the risk of perinatal HIV transmission. Recommendations include increasing adoption of recent World Health Oragnization guidelines on infant feeding and HIV and extending support to cover the first two years of life.

Publication date: March 2008

Region: Global

This document outlines a landscape policy analysis that identified challenges and opportunities for prioritizing diarrheal disease in Malawi.

Publication date: November 2011

Region: Africa

An overview of a diagnostic platform that PATH is developing based on nucleic-acid amplification that will require no instrumentation. It has the dual purpose of providing molecular diagnostics at the point of care as well as stabilizing nucleic-acid specimens for further analysis via a centralized surveillance system. Presented at the American Association for Clinical Chemistry 40th Annual Oak Ridge Conference, April 17, 2008; San Jose, CA.

Author: Weigl B, Domingo G, Gerlach J, et al

Publication date: April 2008

Region: Global

This brief provides policy recommendations to help Tanzania reduce the impacts of pneumonia and diarrhea and ensure all children have the chance to lead healthy lives.

Publication date: April 2014

Region: Africa

Publication date: 2004

Region: Global

This website about PATH’s China country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2014

Region: Asia

Part of series: Program websites

This document provides an overview of seven impact evaluation studies conducted for the China Youth Reproductive Health Project. Summaries of these results for each of the individual studies are also available, as are the full evaluation documents.

Publication date: 2006

Region: Asia

This handbook is an English translation of the Chinese manual created for the China Youth Reproductive Health Project. It includes modules to train counselors in youth-friendly services.

Publication date: February 2004

Region: Asia

Part of the Technology Updates series, this fact sheet describes PATH's work on the use of chlorhexidine for umbilical cord care.

Publication date: July 2013

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH’s work, in collaboration with our partners, to refine a simple test strip for accurate chlorine dosing of water in low-income settings.

Publication date: July 2013

Region: Global

Part of series: Technology Updates

This issue of Outlook looks primarily at vasectomy as a contraceptive option for men. A number of important topics related to this theme are addressed, including no-scalpel vasectomy, no-scalpel vs. conventional vasectomy, choosing vasectomy, cost, vasectomy in developing countries, possible side effects and complications, regret, reversibility, and other strategies for male contraception.

Author: Weil B

Publication date: December 2004

Region: Global

Part of series: Outlook

This poster was presented by PATH's India Microbicide Project at the Microbicides 2004 Conference in London. It describes ciclopiroxolamine, a vaginal product with microbicide potential. Ciclopiroxolamine is a unique microbicide candidate with a long history of proven safety in clinical use as a vaginal and skin product with anti-infective properties. It is already formulated, manufactured, and marketed worldwide in vaginal products. (This project was active from January 2002 to June 2006. It is on hold pending support to obtain additional data on anti-HIV activity.)

Author: Zaneveld LJ; Waller D; Sellors J; Camus-Bablon F

Publication date: 2004

Region: Asia